Literature DB >> 34511835

Early Suspicion of Heparin-Induced Thrombocytopenia for Successful Free Flap Salvage: Reports of Two Cases.

Turan Mehdizade1, Osman Kelahmetoglu1, Volkan Gurkan2, Güven Çetin3, Ethem Guneren1.   

Abstract

Heparin-induced thrombocytopenia (HIT) is an underestimated complication of heparin treatment. Flap loss and related morbidity (even mortality) are caused by occlusion of the capillary vessels by a highly immunogenic complex formed by adherence of antiheparin antibodies to platelet factor 4. Early suspicion and effective treatment of HIT developing in two free flaps are described. We report on the management of two patients with HIT. Both patients were treated successfully by early suspicion and hematology consultation. Heparin products were discontinued; the patients were switched to a nonheparin anticoagulant. We emphasize the importance of early diagnosis, hematologist assessment, and a change to a nonheparin anticoagulant to prevent flap failure and possibly the catastrophic consequences of such failure. Society of Indian Hand & Microsurgeons. All rights reserved. Thieme Medical and Scientific Publishers Pvt. Ltd., A-12, 2nd Floor, Sector 2, Noida-201301 UP, India.

Entities:  

Keywords:  flap; fondaparinux; heparin-induced thrombocytopenia; surgery

Year:  2020        PMID: 34511835      PMCID: PMC8426048          DOI: 10.1055/s-0040-1713692

Source DB:  PubMed          Journal:  J Hand Microsurg        ISSN: 0974-3227


  13 in total

1.  Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.

Authors:  Krystin Krauel; Patricia Preuße; Theodore E Warkentin; Catja Trabhardt; Sven Brandt; Inga Jensch; Martin Mandelkow; Elke Hammer; Sven Hammerschmidt; Andreas Greinacher
Journal:  Blood       Date:  2018-12-20       Impact factor: 22.113

2.  Reconstruction of post-traumatic long segment bone defects of the lower end of the femur by free vascularized fibula combined with allograft (modified Capanna's technique).

Authors:  H Venkatramani; S R Sabapathy; J Dheenadayalan; A Devendra; S Rajasekaran
Journal:  Eur J Trauma Emerg Surg       Date:  2014-09-23       Impact factor: 3.693

3.  Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.

Authors:  Joanne Joseph; David Rabbolini; Anoop K Enjeti; Emmanuel Favaloro; Marie-Christine Kopp; Simon McRae; Leonardo Pasalic; Chee Wee Tan; Christopher M Ward; Beng H Chong
Journal:  Med J Aust       Date:  2019-06-02       Impact factor: 7.738

4.  Recurrent venous thrombosis following free flap surgery: The role of heparin-induced thrombocytopenia.

Authors:  Andreas Nikolis; Apostolos Christopoulos; Michel Saint-Cyr; Carlos Cordoba; Louis Guertin; Patrick G Harris
Journal:  Can J Plast Surg       Date:  2003

5.  Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin; Jo-Ann I Sheppard; Christopher S Sigouin; Thomas Kohlmann; Petra Eichler; Andreas Greinacher
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

6.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Authors:  Nadine Martel; James Lee; Philip S Wells
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

Review 7.  Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors.

Authors:  Kenneth A Bauer; David W Hawkins; Paul C Peters; Maurice Petitou; Jean-Marc Herbert; Constant A A van Boeckel; Dirk G Meuleman
Journal:  Cardiovasc Drug Rev       Date:  2002

8.  Heparin-induced thrombocytopenia syndrome as a cause of flap failure: a report of two cases.

Authors:  Dominique M Tremblay; Patrick G Harris; Alain R Gagnon; Carlos Cordoba; Jean Paul Brutus; Andreas Nikolis
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-02-20       Impact factor: 2.740

Review 9.  Heparin-induced thrombocytopenia: pathophysiology and new treatment options.

Authors:  J Harenberg; I Jörg; T Fenyvesi
Journal:  Pathophysiol Haemost Thromb       Date:  2002 Sep-Dec

10.  Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York.

Authors:  Yazan Samhouri; Mohammad Telfah; Ruth Kouides; Timothy Woodlock
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.